Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ira Makri"'
Autor:
Artemisia Papadima, Stavros Gourgiotis, Emmanuel Lagoudianakis, Apostolos Pappas, Charalampos Seretis, Pantelis T Antonakis, Haridimos Markogiannakis, Ira Makri, Andreas Manouras
Publikováno v:
Saudi Journal of Anaesthesia, Vol 7, Iss 1, Pp 68-74 (2013)
Background: Postoperative nausea and vomiting (PONV) are frequently encountered after thyroidectomy. For PONV prevention, selective serotonin 5-hydroxytryptamine type 3 (5-HT 3 ) receptor antagonists are considered one of the first-line therapy. We r
Externí odkaz:
https://doaj.org/article/d0486c85ee6847d684e357b96bf42db5
Autor:
Karanikas George, Chrysikos D. Ioannis, Artemisia Papadima, Theodoros Xanthos, Seretis Charalambos, Lila Papadimitriou, Koronakis E. Nikolaos, Lagoudianakis E. Emmanuel, Ira Makri, Apostolos Pappas, Aimilia Lafioniati
Publikováno v:
Reviews on recent clinical trials. 6(3)
According to published data, sugammadex, rapidly reverses (2-5 min) shallow and profound NM block induced by rocuronium and vecuronium, without being connected with serious adverse events. It is accepted that in order to reverse shallow block, the su
Autor:
Ira Makri, Artemisia Papadima, Andreas Manouras, Konstantinos Filis, Emmanuel Lagoudianakis, Haridimos Markogiannakis, Pantelis T. Antonakis, Vaggelogiannis Katergiannakis
Publikováno v:
Surgery. 146(3)
Background Laparoscopic cholecystectomy is the treatment of choice for symptomatic cholelithiasis. Postoperative pain, however, can prolong hospital stay and lead to increased morbidity. In the context of a multimodal approach to analgesia, intraperi
Autor:
Haridimos Markogiannakis, Charalampos Seretis, Artemisia Papadima, Stavros Gourgiotis, Andreas Manouras, Pantelis T. Antonakis, Apostolos Pappas, Ira Makri, Emmanuel Lagoudianakis
Publikováno v:
Saudi Journal of Anaesthesia
Saudi Journal of Anaesthesia, Vol 7, Iss 1, Pp 68-74 (2013)
Saudi Journal of Anaesthesia, Vol 7, Iss 1, Pp 68-74 (2013)
Background: Postoperative nausea and vomiting (PONV) are frequently encountered after thyroidectomy. For PONV prevention, selective serotonin 5-hydroxytryptamine type 3 (5-HT 3 ) receptor antagonists are considered one of the first-line therapy. We r